Glanbia Stock CINNOBER BOAT

Equities

GLB

IE0000669501

Food Processing

Delayed CINNOBER BOAT 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Glanbia -.--% -.--%
Sales 2024 * 5.1B 5.46B Sales 2025 * 4.26B 4.56B Capitalization 4.66B 4.99B
Net income 2024 * 286M 306M Net income 2025 * 305M 326M EV / Sales 2024 * 0.95 x
Net Debt 2024 * 165M 177M Net cash position 2025 * 56.16M 60.05M EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
15.2 x
Employees -
Yield 2024 *
2.11%
Yield 2025 *
2.28%
Free-Float 69.88%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 Dec. 31
Director of Finance/CFO 60 13-01-11
Public Communications Contact - 14-11-30
Members of the board TitleAgeSince
Director/Board Member 63 14-11-30
Director/Board Member 68 20-10-31
Director/Board Member 59 20-12-31
More insiders
Glanbia plc specializes in the production and commercialization of dairy, nutritional and food products for the food and pharmaceutical industries. Net sales break down by product family as follows: - nutritional and functional ingredients (66.9%): dairy, vegetable and functional proteins, nutrients (vitamins, trace elements, minerals, etc.), nutritional supplements for children, bioactive ingredients, etc. for dairy and non-dairy products (drinks, cereal bars, snacks, sauces, animal feed, etc.). The group is also developing a cheese production activity; - performance nutrition products (33.1%; world n°1): notably sports nutrition products (Optimum Nutrition, BSN, Isopure, thinkThin, Nutramino, ABB, Body & Fit and Amazing Grass brands). Net sales are distributed geographically as follows: Ireland (0.3%), Europe (8.7%), the United States (79.2%), North America (2%), Asia/Pacific (7%), Latin America (1.8%) and other (1%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
17.86 EUR
Average target price
19.8 EUR
Spread / Average Target
+10.86%
Consensus